newsfilter
← Latest News
GlobeNewswire·

Esperion Partner Otsuka Receives Regulatory Approval to Market NEXLETOL® in Japan for the Treatment of Hypercholesterolemia

ANN ARBOR, Mich., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced that Otsuka Pharmaceutical Co., Ltd. (Otsuka), the Company's partner for the development and commercialization of